Combined with the oncogenic role of RAP2A in tumor cells [24], including renal cell carcinoma [23] and thyroid cancer [30], we thus speculated that RAP2A was the downstream regulator involved in the miR-33a-5p negative regulation of PDAC cell functions. The gene discussed is RAP2A; the disease is hereditary clear cell renal cell carcinoma.